
Cycloferon was used to treat newly diagnosed, recurrent and long-standing pulmonary TB. The dose of 7,5 g combined with antibacterial therapy caused no complications. The effectiveness of this therapy based on the generally-accepted criteria was significantly higher than standard treatment but varied depending on the character of pathological process. It is recommended to use cycloferon in the intense phase of the basal treatment.
Adult, Male, Interferon Inducers, Adolescent, Middle Aged, Drug Administration Schedule, Anti-Bacterial Agents, Immunomodulation, Young Adult, Treatment Outcome, Acridines, Humans, Drug Therapy, Combination, Female, Tuberculosis, Pulmonary
Adult, Male, Interferon Inducers, Adolescent, Middle Aged, Drug Administration Schedule, Anti-Bacterial Agents, Immunomodulation, Young Adult, Treatment Outcome, Acridines, Humans, Drug Therapy, Combination, Female, Tuberculosis, Pulmonary
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
